Schuth Alexander O. 4
4 · Denali Therapeutics Inc. · Filed Aug 22, 2024
Insider Transaction Report
Form 4
Schuth Alexander O.
COFO and Secretary
Transactions
- Sale
Common Stock
2024-08-20$23.79/sh−2,453$58,357→ 183,966 total - Sale
Common Stock
2024-08-21$24.78/sh−2,547$63,115→ 178,066 total - Sale
Common Stock
2024-08-20$23.54/sh−3,353$78,930→ 180,613 total
Holdings
- 523,749(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
- [F2]Includes 118,810 Unvested RSUs.
- [F3]The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023.
- [F4]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.38 to $23.72 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F5]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.19 to $25.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F6]The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.